Useless Until Proven Effective: The Clinical Utility of Preemptive Pharmacogenetic Testing

被引：32

作者：

Janssens, A. C. J. W. ^{[1
,2
]}

Deverka, P. A. ^{[3
]}

机构：

[1] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA

[2] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Amsterdam, Netherlands

[3] Univ N Carolina, Eshelman Sch Pharm, Ctr Pharmacogen & Individualized Therapy, Chapel Hill, NC USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2014年 / 96卷 / 06期

关键词：

D O I：

10.1038/clpt.2014.186

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：652 / 654

页数：3

共 10 条

[1] Systematic review of pharmacoeconomic studies of pharmacogenomic tests [J].

Beaulieu, Mathieu ;

de Denus, Simon ;

Lachaine, Jean .

PHARMACOGENOMICS, 2010, 11 (11) :1573-1590

[2]

BlueCross BlueShield Kaiser Permanente, 2014, CYP2D6 PHARM TAM TRE

[3] Paying for Outcomes: Innovative Coverage and Reimbursement Schemes for Pharmaceuticals [J].

Carlson, Josh J. ;

Garrison, Louis P., Jr. ;

Sullivan, Sean D. .

JOURNAL OF MANAGED CARE PHARMACY, 2009, 15 (08) :683-687

[4] Clinical and economic challenges facing pharmacogenomics [J].

Cohen, J. ;

Wilson, A. ;

Manzolillo, K. .

PHARMACOGENOMICS JOURNAL, 2013, 13 (04) :378-388

[5] The rules remain the same for genomic medicine The case against "reverse genetic exceptionalism" [J].

Evans, James P. ;

Burke, Wylie ;

Khoury, Muin .

GENETICS IN MEDICINE, 2010, 12 (06) :342-343

[6] Launching PCORnet, a national patient-centered clinical research network [J].

Fleurence, Rachael L. ;

Curtis, Lesley H. ;

Califf, Robert M. ;

Platt, Richard ;

Selby, Joe V. ;

Brown, Jeffrey S. .

JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2014, 21 (04) :578-582

[7] The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? [J].

Khoury, Muin J. ;

Gwinn, Marta ;

Yoon, Paula W. ;

Dowling, Nicole ;

Moore, Cynthia A. ;

Bradley, Linda .

GENETICS IN MEDICINE, 2007, 9 (10) :665-674

[8]

Osnabrugge R.L., GENET MED

[9] Clinical Practice Patterns and Cost Effectiveness of Human Epidermal Growth Receptor 2 Testing Strategies in Breast Cancer Patients [J].

Phillips, Kathryn A. ;

Marshall, Deborah A. ;

Haas, Jennifer S. ;

Elkin, Elena B. ;

Liang, Su-Ying ;

Hassett, MichaelJ. ;

Ferrusi, Ilia ;

Brock, Jane E. ;

Van Bebber, Stephanie L. .

CANCER, 2009, 115 (22) :5166-5174

[10] Clinically Actionable Genotypes Among 10,000 Patients With Preemptive Pharmacogenomic Testing [J].

Van Driest, S. L. ;

Shi, Y. ;

Bowton, E. A. ;

Schildcrout, J. S. ;

Peterson, J. F. ;

Pulley, J. ;

Denny, J. C. ;

Roden, D. M. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 (04) :423-431

← 1 →